Pivotal bioVenture Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
1
- Investments
-
55
- Portfolio
-
11
- Exits
-
32
Pivotal bioVenture Partners General Information
Company Description
Founded in 2021, Pivotal bioVenture Partners is a venture capital firm based in San Francisco, California. The firm seeks to invest in companies operating in the therapeutic products and platforms and life sciences sectors.
Business Details
Year Founded
Investor Status
Primary Investor Type
Corporate Office
- 501 2nd Street
- Suite 200
- San Francisco, CA 94107
- United States
Pivotal bioVenture Partners Investments (55)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Obsidian Therapeutics | 03-Aug-2026 | PIPE | Drug Discovery | Clinical Trials - Phase 2 | ||
| Crystalys Therapeutics | 22-Jul-2026 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Trevi Therapeutics | 01-Mar-2026 | Drug Discovery | Generating Revenue | |||
| LB Pharmaceuticals | 04-Feb-2026 | Drug Discovery | Generating Revenue | |||
| Cybin | 31-Oct-2025 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Avalyn Pharma | 22-Jul-2025 | Drug Discovery | Generating Revenue | |||
| Mosanna Therapeutics | 09-Jun-2025 | Drug Discovery | Pre-Clinical Trials | |||
| Trevi Therapeutics | 01-Jun-2025 | Drug Discovery | Generating Revenue | |||
| Evommune | 30-Oct-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Engrail Therapeutics | 14-Mar-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Pivotal bioVenture Partners Exits (32)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Obsidian Therapeutics | 03-Aug-2026 | Reverse Merger | |
| Cybin | 25-Jun-2026 | ||
| Parabilis Medicines | 10-Jun-2026 | ||
| Avalyn Pharma | 30-Apr-2026 | ||
| IO Biotech | 01-Apr-2026 | ||
| Vaxcyte | 02-Feb-2026 | ||
| Evommune | 06-Nov-2025 | ||
| MapLight Therapeutics | 27-Oct-2025 | ||
| Lucy Therapeutics | 01-Jun-2025 | Out of Business | |
| Anthos Therapeutics | 03-Apr-2025 | Merger/Acquisition |
Pivotal bioVenture Partners Investments by Industry, Year, and Region
Pivotal bioVenture Partners Co-Investors (96)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Longwood Fund Management | 3 |
|
|
||
| Norwest |
|
|
|||
| Perceptive Advisors |
|
|
|||
| RA Capital Management |
|
|
|||
| Wellington Management |
|
|
Pivotal bioVenture Partners FAQs
-
What is Pivotal bioVenture Partners?
Founded in 2021, Pivotal bioVenture Partners is a venture capital firm based in San Francisco, California.
-
When was Pivotal bioVenture Partners founded?
Pivotal bioVenture Partners was founded in 2021.
-
Where is Pivotal bioVenture Partners headquartered?
Pivotal bioVenture Partners is headquartered in San Francisco, CA.
-
How many investments has Pivotal bioVenture Partners made?
Pivotal bioVenture Partners has made 55 investments.
-
What has Pivotal bioVenture Partners invested in?
Pivotal bioVenture Partners has made numerous investments in companies like Obsidian Therapeutics, Crystalys Therapeutics, and Trevi Therapeutics within the Drug Discovery industry.
-
What has Pivotal bioVenture Partners invested in recently?
Pivotal bioVenture Partners's latest investment was on 03-Aug-2026 in Obsidian Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process